1642 related articles for article (PubMed ID: 19011436)
1. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
Harakas P; Foulds J
Psychopharmacology (Berl); 2002 May; 161(3):271-7. PubMed ID: 12021830
[TBL] [Abstract][Full Text] [Related]
4. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
Dawkins L; Turner J; Hasna S; Soar K
Addict Behav; 2012 Aug; 37(8):970-3. PubMed ID: 22503574
[TBL] [Abstract][Full Text] [Related]
5. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G
Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412
[TBL] [Abstract][Full Text] [Related]
7. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
[TBL] [Abstract][Full Text] [Related]
8. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
Bullen C; McRobbie H; Thornley S; Glover M; Lin R; Laugesen M
Tob Control; 2010 Apr; 19(2):98-103. PubMed ID: 20378585
[TBL] [Abstract][Full Text] [Related]
9. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
Potter AS; Newhouse PA
Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
[TBL] [Abstract][Full Text] [Related]
10. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Myers CS; Taylor RC; Moolchan ET; Heishman SJ
Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
[TBL] [Abstract][Full Text] [Related]
11. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
12. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
13. The effects of varying cigarette deprivation duration on cognitive and performance tasks.
Hatsukami D; Fletcher L; Morgan S; Keenan R; Amble P
J Subst Abuse; 1989; 1(4):407-16. PubMed ID: 2485288
[TBL] [Abstract][Full Text] [Related]
14. Modafinil and nicotine interactions in abstinent smokers.
Sofuoglu M; Waters AJ; Mooney M
Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
[TBL] [Abstract][Full Text] [Related]
15. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
16. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
Ray R; Rukstalis M; Jepson C; Strasser A; Patterson F; Lynch K; Lerman C
J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446
[TBL] [Abstract][Full Text] [Related]
17. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
Cappelleri JC; Bushmakin AG; Baker CL; Merikle E; Olufade AO; Gilbert DG
Curr Med Res Opin; 2005 May; 21(5):749-60. PubMed ID: 15969874
[TBL] [Abstract][Full Text] [Related]
18. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
Poltavski DV; Petros T
Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
[TBL] [Abstract][Full Text] [Related]
19. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers.
Jacobsen LK; Krystal JH; Mencl WE; Westerveld M; Frost SJ; Pugh KR
Biol Psychiatry; 2005 Jan; 57(1):56-66. PubMed ID: 15607301
[TBL] [Abstract][Full Text] [Related]
20. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
